tiprankstipranks
Trending News
More News >

ALISON MOORE Insider Profile

4 Followers
ALISON MOORE, CTO at Allogene Therapeutics, holds 169.33K shares in Codexis (Ticker: CDXS), holds 672.73K shares in Allogene Therapeutics (Ticker: ALLO), holds ― shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV). Most recently, ALISON MOORE Sold ― shares of Codexis on Oct 15, 2025 for an estimated value of $15.60K.
tipranks
ALISON MOORE

ALISON MOORE
Allogene Therapeutics (ALLO)
CTO

Not Ranked
ALISON MOORE has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
64.84%
35.16%
0.00%
A breakdown of ALISON MOORE's holdings

Insider Roles

Allogene Therapeutics
(ALLO)
CTO
Codexis
(CDXS)
CTO
Artiva Biotherapeutics, Inc.
(ARTV)
Director
Roles that ALISON MOORE holds in companies

Most Profitable Insider Trade

Stock:
Codexis
(CDXS)
Rating:Informative Sell
Date:Oct 15, 2025 - Today
Return:+3.20%
The most profitable trade made by ALISON MOORE

ALISON MOORE's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Allogene Therapeutics
Mar 24, 2023
CTO
Uninformative Buy
$827.46K
Codexis
Oct 15, 2025
CTO
Informative Sell
15.60K
$448.73K
Artiva Biotherapeutics, Inc.
Director
List of latest transactions for each holding click on a transaction to see ALISON MOORE's performance on stock

ALISON MOORE insider profile FAQ

What is the percentage of profitable transactions made by ALISON MOORE?
The percentage of profitable transactions made by ALISON MOORE is ―.
    What is the average return per transaction made by ALISON MOORE?
    The average return per transaction made by ALISON MOORE is ―.
      What stocks does ALISON MOORE hold?
      ALISON MOORE holds: ALLO, CDXS, ARTV stocks.
        What was ALISON MOORE’s latest transaction?
        ALISON MOORE latest transaction was an Informative Sell of $15.60K.
          What was ALISON MOORE's most profitable transaction?
          ALISON MOORE’s most profitable transaction was an Informative Sell of CDXS stock on October 15, 2025. The return on the trade was 3.20%.
            What is ALISON MOORE's role in Allogene Therapeutics?
            ALISON MOORE's role in Allogene Therapeutics is CTO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.